UPDATED May 15, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
11B | zł590.00 | 3.7% | -9.2% | zł1.4b | zł699.86 | PE2713.3x | E27.7% | n/a | Media | ||
XTP | zł129.20 | -1.8% | 5.0% | zł293.2m | zł216.00 | PS18.9x | E124.6% | n/a | Tech | ||
SHO | zł40.00 | 3.1% | 23.5% | zł1.1b | zł41.17 | PE38.9x | E23.8% | 0.03% | Software | ||
VGO | zł502.00 | 8.0% | -17.7% | zł439.1m | zł591.50 | PE85.6x | E37.3% | 0% | Tech | ||
VRC | zł130.00 | 11.1% | 140.7% | zł2.9b | zł123.83 | PE40.9x | E21.8% | 1.2% | Software | ||
CRJ | zł559.00 | -1.6% | -31.0% | zł390.9m | zł642.61 | PE21.3x | E19.7% | 2.3% | Media | ||
PTG | zł49.40 | 2.9% | -3.5% | zł230.4m | zł68.20 | PS164.7x | E8.2% | n/a | Pharmaceuticals & Biotech | ||
CDR | zł139.65 | 6.0% | 27.9% | zł14.0b | zł112.94 | PE29x | E23.6% | 0.7% | Media | ||
CIG | zł1.80 | -0.2% | -72.2% | zł328.4m | zł4.80 | PE25.2x | E75.1% | n/a | Media | ||
APT | zł15.36 | 2.7% | -5.2% | zł446.2m | zł17.70 | PE25x | E57.3% | 2.6% | Tech |